Education
About Us
Working with TipRanks
Follow Us
PAUL HARTMANN AG (DE:PHH2)
:PHH2
PHH2 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€183.00 - €258.00
Previous CloseN/A
Volume0.00
Average Volume (3M)35.00
Market Cap
€873.73M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)251.55M
Price to Earnings (P/E)8.1
Beta0.38
Next Earnings
Mar 19, 2026EPS EstimateN/A
Last Dividend Ex-Date
May 02, 2025Dividend Yield3.25%
Share Statistics
EPS (TTM)18.48
Shares Outstanding3,572,424
10 Day Avg. Volume16
30 Day Avg. Volume35
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
<0.01%
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
PHH2 FAQ
What was PAUL HARTMANN AG’s price range in the past 12 months?
PAUL HARTMANN AG lowest stock price was €183.00 and its highest was €258.00 in the past 12 months.
What is PAUL HARTMANN AG’s market cap?
PAUL HARTMANN AG’s market cap is €873.73M.
When is PAUL HARTMANN AG’s upcoming earnings report date?
PAUL HARTMANN AG’s upcoming earnings report date is Mar 19, 2026 which is in 245 days.
How were PAUL HARTMANN AG’s earnings last quarter?
Currently, no data Available
Is PAUL HARTMANN AG overvalued?
According to Wall Street analysts PAUL HARTMANN AG’s price is currently Overvalued.
Does PAUL HARTMANN AG pay dividends?
PAUL HARTMANN AG pays a Annually dividend of €8 which represents an annual dividend yield of 3.25%. See more information on PAUL HARTMANN AG dividends here
What is PAUL HARTMANN AG’s EPS estimate?
PAUL HARTMANN AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PAUL HARTMANN AG have?
PAUL HARTMANN AG has 3,572,424 shares outstanding.
What happened to PAUL HARTMANN AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PAUL HARTMANN AG?
Currently, no hedge funds are holding shares in DE:PHH2
PAUL HARTMANN AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth €300.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.29%
12-Months-Change
Fundamentals
Return on Equity
9.81%
Trailing 12-Months
Asset Growth
7.98%
Trailing 12-Months
Company Description
PAUL HARTMANN AG
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
Technical Analysis
Biotest
―
CompuGroup Medical
―
Draegerwerk AG & Co. KGaA
―
RHON-KLINIKUM AG
―
Medios AG
―